Literature DB >> 3142077

HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.

T F Wolfs1, C Breederveld, W J Krone, L vd Hoek, M Bakker, L Smit, J Goudsmit.   

Abstract

A national multicentre study was performed to investigate the effects of donorselection and the use of heat-treated plasma products on seroconversion to HIV in 157 Dutch haemophiliacs. All patients included in the study were seronegative for HIV antibodies in 1983. Thirteen percent (20/157) seroconverted between 1983 and 1986. Nineteen of 20 seroconversions could be related to the use of non heat-treated products in the year preceding HIV antibody seroconversion. One seroconversion occurred in a person using heat-treated non donor screened product. Seroconversion rate decreased as a result of the policy to discourage high risk blood donors and no seroconversions were observed following the introduction of donor screening in 1985.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142077

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  HIV transmission in the provision of health care.

Authors:  H Houweling
Journal:  Clin Investig       Date:  1993-12

2.  Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage.

Authors:  C A Boucher; M H de Jager; C Debouck; L G Epstein; F de Wolf; T F Wolfs; J Goudsmit
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

3.  Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.

Authors:  C L Kuiken; G Zwart; E Baan; R A Coutinho; J A van den Hoek; J Goudsmit
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.

Authors:  C Smit; F R Rosendaal; I Varekamp; A Bröcker-Vriends; H Van Dijck; T P Suurmeijer; E Briët
Journal:  BMJ       Date:  1989-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.